Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Levitzki

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Biochemistry|April 3, 2007
A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathwayPninit Litman, Osnat Ohne, Shirly Ben-Yaakov, et al.
Bioorganic & Medicinal Chemistry|January 25, 2014
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I)Zhenghong Peng, David S Maxwell, Duoli Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Biochemistry|April 3, 2007
A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathwayPninit Litman, Osnat Ohne, Shirly Ben-Yaakov, et al.
Bioorganic & Medicinal Chemistry|January 25, 2014
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I)Zhenghong Peng, David S Maxwell, Duoli Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Pageof 10